P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles

• Chiara Rusconi,
• Francesca Ricci,
• Vittorio R. Zilioli,
• Vincenzo Marasco,
• Eleonora Calabretta,
• Anna Guidetti,
• Cristina Muzi,
• Federico Mazzon,
• Margherita Smania,
• Martina Sollini,
• Erika Meli,
• Marcello Rodari,
• Emanuele Ravano,
• Roberto Cairoli,
• Paolo Corradini,
• Armando Santoro

Affiliations

Chiara Rusconi

1 Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy

Francesca Ricci

2 Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy

Vittorio R. Zilioli

3 Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Vincenzo Marasco

1 Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy

Eleonora Calabretta

4 Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy

Anna Guidetti

1 Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy

Cristina Muzi

3 Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Federico Mazzon

5 University of Milan, Milano, Italy

Margherita Smania

5 University of Milan, Milano, Italy

Martina Sollini

6 Unit of Nuclear Medicine, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy

Erika Meli

3 Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Marcello Rodari

6 Unit of Nuclear Medicine, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy

Emanuele Ravano

3 Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Roberto Cairoli

3 Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Paolo Corradini

1 Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy

Armando Santoro

2 Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy